Thanks Ethan!
07.03.2026 22:10
👍 1
🔁 0
💬 0
📌 0
Can recommend. This is a great talk
04.03.2026 01:48
👍 1
🔁 0
💬 0
📌 0
2026 Midwest C. elegans Meeting
Join us for 2026 Midwest C. elegans Meeting at Van Andel Institute Stay informed about exciting upcoming events and activities.
Reminder that we are still running a free 1 day Midwest worm meeting this year for all students/labs that either can’t go to MAPSS/DevCell or want a smaller audience (~100 last year) to present to. www.vai.org/event/2026-m...
24.02.2026 00:40
👍 5
🔁 1
💬 0
📌 0
Ugh. I hope it’s not a broader change
22.01.2026 18:25
👍 0
🔁 0
💬 2
📌 0
Anecdotally, I got this same feedback this year for the first time from NIH and hadn’t previously on the same topic. I’m still hopeful that it’s a bit study section specific or topic specific rather than worms though. Perhaps we both got that feedback on the same general topic?
22.01.2026 15:33
👍 1
🔁 0
💬 1
📌 0
2026 VAI Epigenetics Symposium, May 11-13, 2026
🧬🪰🐀🪱🧑🤝🧑Join me and my co-organizers @andrewpospisilik.bsky.social @nickburton.bsky.social Derek Jannssens and Piroska Szabó for the 2026 VAI Epigenetics Symposium @vai.org.
The meeting is centered around phenotypic plasticity and variation.
For more specific topics check:
www.vai.org/event/2026-v...
04.12.2025 18:00
👍 3
🔁 2
💬 0
📌 0
Two at once! Congrats!
22.11.2025 02:07
👍 1
🔁 0
💬 1
📌 0
If you look at NIH reporter this problem seems to have recently changed and several (many?) new R01s for nigms have come in. I have heard that NIGMS now aims for a 60/40 split R35/R01. Also, fwiw, I am neither ESI nor a new investigator so afraid those options won’t apply for me but will for others!
23.09.2025 17:21
👍 0
🔁 0
💬 0
📌 0
Don’t want to overstate it, but as people here might know I’m also a big fan of “fundamental” or “old-school” techniques/approaches in science and an advocate of them
18.08.2025 21:36
👍 2
🔁 0
💬 0
📌 0
Just replace analytics with “mathematical model” or AI or some similar buzz word
18.08.2025 21:25
👍 0
🔁 0
💬 1
📌 0
I’m sure @razzball.bsky.social never thought he’d be retweeted in the realm of science for this, but this is as true in science as it is in baseball and I’m really liking the parallels across spheres here
18.08.2025 21:24
👍 3
🔁 0
💬 2
📌 0
Thanks Ilaria!
13.08.2025 01:44
👍 1
🔁 0
💬 0
📌 0
Thanks Eugene!
13.08.2025 01:44
👍 0
🔁 0
💬 0
📌 0
Thanks Natalie!!
12.08.2025 17:55
👍 0
🔁 0
💬 0
📌 0
Thanks Walter! Maybe I’ll see you at this once you open up your new lab with all that exciting work!!!
12.08.2025 17:42
👍 1
🔁 0
💬 0
📌 0
Thanks Caroline! How’s the new lab set up going? Once you’re up and running hopefully we can get you out to VAI Metabolism dept for a talk. Would love to hear more about your stuff!
12.08.2025 15:48
👍 1
🔁 0
💬 0
📌 0
With that said it does feel odd to post happy science funding news in times such as these. However this, coupled with an NoA on an R21 with @saranowinski.bsky.social really feels like a win in a time where wins are hard to come by and an important point in my career. So guess I need to celebrate?!?
12.08.2025 15:41
👍 2
🔁 0
💬 0
📌 0
This is equal parts an honor and thank you to all the people who trained me, wrote letters, my lab members etc. Really looking forward to the next four years and annual meetings.
12.08.2025 15:41
👍 0
🔁 0
💬 1
📌 0
Pew Awards 22 Researchers Biomedical Science Grants
I’m really beyond thrilled to be included in this years Pew Biomedical Scholars cohort and to be able to meet all the incredible scientists in this program. I was in Scott Kennedy’s lab when he was a Pew Scholar and never thought I’d be lucky enough to also be one! www.pew.org/en/about/new...
12.08.2025 15:41
👍 27
🔁 3
💬 8
📌 0
Congrats!!!
10.07.2025 17:47
👍 1
🔁 0
💬 0
📌 0
Thanks Swathi! They both are, hope everything is well with you too!
02.07.2025 23:22
👍 1
🔁 0
💬 0
📌 0
So sad to have missed #worm25. With a relative new kid, and selling my house (offer accepted during worm meeting) it was just a bit impossible to also get to Davis. I did hear multiple of my lab members had a great time even if all I experienced was FOMO
02.07.2025 22:54
👍 19
🔁 0
💬 1
📌 0
Associate or Senior Editor Nature Metabolism
Job Title: Associate or Senior Editor Nature Metabolism Location: New York, Beijing or Shanghai Application Deadline: June 10th, 2025 About Springer Nature Group Springer Nature opens the doors to discovery for researchers, educators, clinicians and other professionals. Every day, around the globe, our imprints, books, journals, platforms and technology solutions reach millions of people. For over 180 years our brands and imprints have been a trusted source of knowledge to these communities and today, more than ever, we see it as our responsibility to ensure that fundamental knowledge can be found, verified, understood and used by our communities – enabling them to improve outcomes, make progress, and benefit the generations that follow. Visit http://group.springernature.com/ and follow @SpringerNature / @SpringerNatureGroup. About the Brand Nature Portfolio is a flagship portfolio of journals, products and services including Nature and the Nature-branded journals, dedicated to serving the scientific community. Visit nature.com and follow @Nature / @NaturePortfolio. About the Role Nature Metabolism seeks an Associate or Senior Editor to join our expanding editorial team. Do you love science but feel that a research career isn’t enough to sate your desire to learn more about the natural world? Do you enjoy reading papers outside your chosen area of research? If the answer is ‘yes’ to any or both questions, you could be the person we’re looking for to join the editorial team of Nature Metabolism. This role can be in our New York, Beijing or Shanghai offices on a hybrid working model. Role Responsibilities: Working closely with other editors on all aspects of the editorial process, including manuscript selection and overseeing peer review. Commissioning and editing News & Views and Reviews articles and writing for the journal. Organizing and attending conferences and visiting laboratories. Maintaining close contact with the international scientific community. The role requires broad scientific interest and strong interpersonal, communication, and organizational skills. Fluency in spoken and written English, along with a willingness to learn and engage with the scientific community, is essential. Experience, Skills & Qualifications: A Ph.D. in a relevant research field is required. Postdoctoral research experience is preferred but not essential A broad interest in science and the ability to critically evaluate research submitted to the journal Applications from all scientific areas covered by the journal are welcome but candidates with expertise in cellular metabolic biology (e.g. mitochondrial biology), metabolic biochemistry or metabolic tracing are especially encouraged. Experience in cancer research or immunology is a plus. Excellent interpersonal, communication and organizational skills Fluent in spoken and written English To Apply: Please submit a cover letter explaining your interest in the position and your salary expectations please submit a CV concise (up to 500 words) discussion of recent developments or trends in the wider metabolism field, which you have found particularly exciting (and explaining why). Springer Nature US provides a comprehensive and competitive benefits package which includes the benefit offerings listed below: • Medical, Dental and Vision • 401(k) with company match and contribution • Hybrid office working policy, Summer Hours, and paid time off • Flexible Spending and Commuter programs • Multiple Life insurance options • Disability coverage • Tuition Assistance • Voluntary benefits: Identity Theft Protection, Pet Insurance, and Legal Assistance Insurance • Employee Assistance Program • Family friendly benefits and a variety of employee discounts • An array of Employee Social Networks US Annualized Base Salary Range: Associate Editor: $80,000 | Senior Editor: $95,000. The salary offer may vary based on work experience, education, skill level and equity. The US salary range does not align with the salary ranges in other countries when converted to the currency of that country. Springer Nature is an Equal Opportunity Employer that complies with the laws and regulations set forth in the following https://www.eeoc.gov/sites/default/files/2023-06/22-088_EEOC_KnowYourRights6.12ScreenRdr.pdf At Springer Nature, we value the diversity of our teams and work to build an inclusive culture, where people are treated fairly and can bring their differences to work and thrive. We empower our colleagues and value their diverse perspectives as we strive to attract, nurture and develop the very best talent. Springer Nature was awarded Diversity Team of the Year at the 2022 British Diversity Awards. Find out more about our DEI work here: https://group.springernature.com/gp/group/taking-responsibility/diversity-equity-inclusion If you have any access needs related to disability, neurodivergence or a chronic condition, please contact us so we can make all necessary accommodation. For more information about career opportunities in Springer Nature please visit https://careers.springernature.com/ #LI-DT1 Job Posting End Date: 11-06-2025 We are an ambitious and dynamic organisation, and home to some of the best-known names in research, educational and professional publishing. Working at the heart of a changing industry, we are always looking for great people who care about delivering quality to our customers and the communities we work alongside. In return, you will find that we open the doors to discovery for all our employees – offering opportunities to learn from some of the best in the business, with a culture that encourages curiosity and empowers people to find solutions and act on their instincts. Whether you are at the beginning of your career or are an experienced professional, we invite you to find out more about the roles we offer and explore our current vacancies. We are a global and progressive business, founded on a heritage of trusted and respected brands – including Springer, founded in 1842, Macmillan, founded in 1843 and Nature, first published in 1869. Nearly two centuries of progress and advancement in science and education have helped shape the business we are today. Research and learning continues to be the cornerstone of progress, and we will continue to open doors to discovery through trusted brands and innovative products and services. Springer Nature Group was created in May 2015 through the combination of Nature Publishing Group, Macmillan Education and Springer Science+Business Media.
🚨Job Alert!🚨
@natmetabolism.nature.com seeks an Associate or Senior #Editor to join our team. If being a #Metabolism Editor is for you, and you are based in, or open to moving to New York or Shanghai, check out our #job posting below and apply before June 11th.
01.06.2025 16:27
👍 2
🔁 5
💬 0
📌 0
This sounds exciting
31.05.2025 18:08
👍 2
🔁 0
💬 0
📌 0
Postdoctoral Associate in IBD genetics in C. elegans and organoids
Post a job in 3min, or find thousands of job offers like this one at jobRxiv!
Opening for a #postdoc in the lab available immediately. Please spread the word.
DETAILS HERE: jobrxiv.org/job/baylor-c...
cc: #academicJobs #postdocJobs #microbiome #Celegans #organoids #IBD #PathSky #Medsky #AcademicSky 🧪 🧬 🦠
31.05.2025 16:28
👍 13
🔁 27
💬 0
📌 5
Thanks. Sadly I wont be at worm meeting but two of my lab members will be. Newish kid at home and might be moving houses that week and all a bit difficult to line up given all the other travel I've had to do recently. Really, really, really sad to have to miss it though. Pained me to know id miss it
21.05.2025 13:05
👍 0
🔁 0
💬 0
📌 0
Hold up is this real? I’m a bit stunned this isn’t talked about more in the circles I run in on here. Would be a big deal for how basic science is funded.
20.05.2025 23:51
👍 0
🔁 1
💬 2
📌 0
Thanks. This one has been a bit of a saga already, but I guess that's what happens when you're trying to push the envelope. I do think some reviewer comments on this have already really strengthened the paper which is why we pulled it to collect more data for 6 months. Its a much much better version
20.05.2025 20:09
👍 0
🔁 0
💬 1
📌 0
